Abstract

Novel Agents and Future Prospects in the Treatment of Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma is one of the most aggressive malignancies and the fourth leading cause of cancer-relatedmortality in the United States. The majority of patients are diagnosed at advanced stage with inoperable locally advancedtumors or metastatic disease, and palliative chemotherapy remains the best therapeutic option for these patients. Despiteintensive clinical and pre-clinical research over the last few years, the combination of the anti-metabolite drug gemcitabinewith the targeted agent erlotinib, is considered standard of care in the treatment of these patients, with only minimal ormodest efficacy. Therefore, novel therapeutic approaches are currently under clinical investigation in an attempt to producemore definite results for this fatal disease. In this paper we summarize five most interesting research abstracts as presentedat the 2013 American Society of Clinical Oncology (ASCO) Annual Meeting. In two studies, nimotuzumab, a monoclonalantibody against epidermal growth factor receptor (EGFR) (Abstract #4009) and bavituximab, a monoclonal antibodyagainst phosphatidylserine (Abstract #4054) are tested in combination with gemcitabine in patients with advancedpancreatic cancer. Abstract #4012 is a study of gemcitabine with vismodegib, a novel hedgehog pathway inhibitor, whereasin Abstract #4035, toxicity and efficacy results of sunitinib in combination with gemcitabine in patients with pancreaticadenocarcinoma are presented. Lastly, safety results of pimasertib, a novel mitogen-activated protein kinase kinase (MEK)inhibitor, combined with the standard gemcitabine are presented in Abstract #4041.


Author(s):

Muhammad Wasif Saif, Konstantinos N Syrigos, Evangelos G Sarris



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Abstracted/Indexed in

  • Index Copernicus
  • Academic Journals Database
  • Genamics JournalSeek
  • Academic Keys
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • British Library
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Emerging Sources Citation Index (ESCI)
  • EBSCO Host
  • MIAR
  • International Committee of Medical Journal Editors (ICMJE)
  • University of Zurich - UZH
  • University Grants Commission
  • SWB Online-Katalog
  • Scholarsteer
  • Geneva Foundation for Medical Education and Research
  • Secret Search Engine Labs
Flyer image